Found 373 matching trials
RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP PHASE1 The purpose of this study is to look at the levels of three HIV medications...
Show More Location
Chelsea and Westminster Hospital NHS Foundation Trust
Learn More & Join Trial
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects PHASE3 The purpose of Study GS-01-934 was to assess the efficacy and safety of two...
Show More Location
AIDS Healthcare Foundation Research
Learn More & Join Trial
Botswana TDF/FTC Oral HIV Prophylaxis Trial PHASE2 This study tested whether taking a pill of tenofovir and emtricitabine (two...
Show More Location
Centers for Disease Control and Prevention
Learn More & Join Trial
Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC PHASE3 The primary objective of this study in antiretroviral (ARV)-naïve Human imm...
Show More Location
Multiple Locations
Learn More & Join Trial
Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir PHASE4 Bioequivalence study of two formulations containing a fixed dose combinatio...
Show More Learn More & Join Trial
Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens PHASE4 The study will determine tissue pharmacology of a single dose of doxycyclin...
Show More Learn More & Join Trial
Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects PHASE2 A prospective, randomized, open-label pilot study to assess virologic suppr...
Show More Location
University of Miami AIDS Clinical Research Unit
Learn More & Join Trial
HIV PrEP Priming of Immune Effectors PHASE4 Can HIV-specific immunity develop in HIV uninfected humans exposed to HIV w...
Show More Location
MRC/UVRI Uganda Research Unit on Aids - Good Health for Women Project
Learn More & Join Trial
Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test PHASE4 The purpose of this study is to evaluate the efficacy of DTG + 3TC versus D...
Show More Learn More & Join Trial
Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW PHASE1 This is a research study to determine the best way to dose Truvada®, an ora...
Show More Location
Johns Hopkins School of Medicine Drug Development Unit
Learn More & Join Trial